Clinical Study

99mTc-DMSA (V) in Evaluation of Osteosarcoma: Comparative Studies with 18F-FDG PET/CT in Detection of Primary and Malignant Lesions

Table 2

Individual patient’s characteristics describing the age, sex, primary site involved, histopathological subtype, and metastatic involvement of lung or any other site.

Patient no.Age (y)SexPrimary siteSubtypeLung metsOther sites

148FRt HumerusN/APN/I
216MRt TibiaMMTPN/I
313FRt FemurN/ANN/I
417MRt HumerusN/APN/I
513MRt FemurN/APN/I
624MRt Chest wallN/ANN/I
714MLt FemurCDBNN/I
824MRt FemurN/APN/I
966MRt FemurN/APN/I
1019MRt FemurOsteoclastic typePLeft scapula
1114FLt ClavicleCDBNN/I
1225MRt FemurSpindle cells with necrosis Osteoid+NN/I
1328FLt HumerusMMTNN/I
1411MLt FemurMMTNN/I
1535FLt TibiaMMTPN/I
168FLt FemurN/APN/I
178FRt FemurN/APN/I
1824MLt FemurN/ANN/I
1916MLt TibiaN/ANN/I
2010FLt FibulaN/ANN/I
2117MLt FibulaMMTNN/I
2224MRt JawSpindle cells (freq. mitosis and high labelling index, MIB-I)NN/I

F: female, M: male, Rt: right, Lt: left, N/A: not available, CDB: chondroblastic differentiation, MMT: malignant mesenchymal tumor, P: positive, N: negative, N/I: not involved.